SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
UnitedHealth says wide swath of patient files may have been taken in Change cyberattack
Core blimey: French apple rose tart
San Bernardino police arrest teen for murder of 14
Space X: Rocket set to slam into moon wrongly blamed on Elon Musk
GoFundMe expands into Mexico as part of for
Core blimey: Poached pears with blackberry drizzle and hazelnut shortbread
Food writer baffles This Morning viewers with tips for cheap lunches
Met Gala 2024: The theme, who's hosting and what else to know
Why Kate Middleton waited to announce her cancer diagnosis
Row as Rishi Sunak lines up ex
How Lady Louise Windsor is tipped for a key role in Prince William's future monarchy